A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease. With this new resource, called ImmGenMaps, researchers are building a map of ...
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results